Of note, PLG/plasmin that is generated by the action of PLAT (plasminogen activator, tissue type) is highly reduced in MS resulting in the reduction of the proteolytic conversion of proBDNF to BDNF. This evidence concerns the gene PLG and myeloid sarcoma.